Snapshot from Jul 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / FTC sues Hims & Hers
Regulatory regulatory lawsuit

FTC sues Hims & Hers

Analysis based on 6 articles · First reported Jul 29, 2026 · Last updated Jul 30, 2026

Sentiment
-30
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

Hims & Hers Health stock dropped around 12-14% following the lawsuit announcement, reflecting investor concern over potential fines and reputational damage. The case may also increase regulatory scrutiny on telehealth data practices, affecting the broader industry.

telehealth healthcare advertising technology
Event Summary

The United States — Federal Trade Commission, along with United States — Utah and United States — California, filed a lawsuit against telehealth company Hims & Hers Health Health, alleging deceptive privacy and billing practices. The FTC claims Hims & Hers Health shared consumers' sensitive health information with third-party advertising platforms like Meta and Snap, despite promising privacy. The company is also accused of charging customers for prescriptions before they consult with a provider and making it difficult to cancel subscriptions. Hims & Hers Health denies the allegations and says it will vigorously defend itself. The stock fell about 12-14% on the news.

Key Actions
100 United States — Federal Trade Commission sued Hims & Hers Health
80 Hims & Hers Health shared health data Meta Platforms
80 Hims & Hers Health shared health data Snap Inc.
70 Hims & Hers Health charged users prematurely
60 Hims & Hers Health made cancellation difficult
50 United States — Federal Trade Commission joined by United States — Utah
50 United States — Federal Trade Commission joined by United States — California
Entities Involved
govactor
United States — Federal Trade Commission
The FTC is the lead plaintiff, alleging violations of consumer protection laws.
Importance 100.0 Sentiment 0.0
stock
Hims & Hers Health
The company faces a federal lawsuit that could result in fines and operational changes; its stock dropped significantly.
Importance 100.0 Sentiment -70.0
stock
Meta Platforms
Meta is named as a recipient of shared health data, potentially facing reputational harm.
Importance 40.0 Sentiment -10.0
loc
United States — Utah
United States — Utah joined the lawsuit, alleging violations of its Consumer Sales Practices Act.
Importance 30.0 Sentiment 0.0
loc
United States — California
United States — California joined the lawsuit, alleging violations of its false advertising and unfair competition laws.
Importance 30.0 Sentiment 0.0
stock
Snap Inc.
Snap is named as a recipient of shared health data, potentially facing reputational harm.
Importance 30.0 Sentiment -10.0
per
Chris Mufarrige
As Director of the FTC's Bureau of Consumer Protection, Mufarrige announced the lawsuit.
Importance 20.0 Sentiment 0.0
Relationships
United States — Federal Trade Commission related ↔ Hims & Hers Health
United States — Federal Trade Commission related ↔ Meta Platforms
United States — Federal Trade Commission related ↔ Snap Inc.
Meta Platforms related ↔ Snap Inc.
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.